Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Vimian Group AB ( (SE:VIMIAN) ) has provided an update.
Vimian Group AB’s Annual General Meeting approved the 2025 financial statements, discharged the board and CEOs from liability, and decided that no dividend will be paid, with profits carried forward. Shareholders re-elected the existing five-member board, confirmed Magnus Welander as chair, reappointed Grant Thornton Sweden AB as auditor, and set board and committee remuneration levels.
The meeting authorised the board to issue new shares of up to 20 percent of the outstanding share capital and to repurchase up to 10 percent of the company’s own shares to optimise capital structure, enable share-based transactions, and support incentive schemes. Shareholders also approved a new Articles of Association introducing reclassifiable and redeemable share classes for incentive use, and adopted a long-term performance-based share programme, LTIP 2026/2029, underlining Vimian’s focus on employee alignment and long-term value creation.
The most recent analyst rating on (SE:VIMIAN) stock is a Hold with a SEK37.00 price target. To see the full list of analyst forecasts on Vimian Group AB stock, see the SE:VIMIAN Stock Forecast page.
More about Vimian Group AB
Vimian Group AB is a Swedish publicly listed company operating in the animal health sector, focusing on specialized veterinary products and services. The group targets a global market for advanced care solutions for companion and production animals, positioning itself as a consolidator and growth platform in veterinary pharmaceuticals and related technologies.
Average Trading Volume: 299,245
Technical Sentiment Signal: Hold
Current Market Cap: SEK15.02B
See more data about VIMIAN stock on TipRanks’ Stock Analysis page.

